Clinical trial
Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the…
NCT00113178 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00113178 |
|---|---|
| Title | Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter |
| Official title | Clinical Study to Evaluate the Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Cavo-Tricuspid Valve Isthmus-Dependent Atrial Flutter |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Flutter |
| Intervention type | Device |
| Interventions | Catheter-based cardiac cryoablation |
| Enrollment | 160 |
| Start date | Jan 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Jun 7, 2005 |
| Last update posted | Feb 24, 2011 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: